<?xml version="1.0" encoding="UTF-8"?>
<document id="30513729">
	<sentence id="s1" text="These effects are thought to have a significant negative regulation of transcription by RNA polymerase II upon both vascular and cerebrovascular health, ultimately with the potential to prevent cardiovascular and potentially neurodegenerative disease with a vascular component, for example vascular dementia.">
		<entity id="s1.e1" charOffset="48-105"
			type="GO" text="negative regulation of transcription by RNA polymerase II" ontology_id="GO_0000122"/>
		<entity id="s1.e2" charOffset="225-250"
			type="HP" text="neurodegenerative disease" ontology_id="HP_0002180"/>
		<pair id="s1.p1" e1="s1.e1"
		    e2="s1.e2" pgr="false"/>
	</sentence>
	<sentence id="s2" text="However, there is adenylate cyclase-activating G protein-coupled receptor signaling pathway variation in the literature due to the heterogeneous nature of the randomised controlled trials conducted.">
		<entity id="s2.e1" charOffset="18-91"
			type="GO" text="adenylate cyclase-activating G protein-coupled receptor signaling pathway" ontology_id="GO_0007189"/>
		<entity id="s2.e2" charOffset="131-144"
			type="HP" text="heterogeneous" ontology_id="HP_0001425"/>
		<pair id="s2.p1" e1="s2.e1"
		    e2="s2.e2" pgr="false"/>
	</sentence>
</document>
